impt-514
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2023 (NCT06153095)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatitis B virusINHIBITOR
Hepatitis B virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06462144 | Early Phase 1 (Phase 1) | Jun 13, 2024 | Nanjing University |
| NCT06153095 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2023 | Immpact Bio |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immpact Bio | For profit | 1 | 1 | 1 | 2023 |
| Nanjing University | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1